Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Fournier’s gangrene

posted 53 mins

Shared 0 times

Urology News - Introduction Fournier’s gangrene (FG) is a rare but fulminant form of infective necrotising fasciitis affecting the perineum and external genitalia, which can rapidly progress...

AUA Research Weekend (2020) | AUA University

posted 1 hour

Shared 1 times

auau.auanet.org - Basic Sciences Symposium: Novel Technologies for Benign Urology ResearchWelcome and Opening Remarks, Margot Damaser, PhD and Robert W. Gereau IV, PhDSession One: Tissue Engineering...

UroToday - systemic treatment of metastatic clear cell renal cell carcinoma, best treatment combination for first-line setting, studies on combination IO therapies, comparison with sunitinib for...

UroToday - PSMA Targeted Therapies in Progressive Metastatic Prostate Cancer Module 7 9 minutes: Academic Practice Perspectives on Integrating PSMA Lu-177 into Clinical Practice: Lessons Learned...

UroToday - In an area where we have multiple options for treatment and we continue to have more data that helps to guide us, Evan Yu...

Post-prostatectomy incontinence

posted 3 hours

Shared 0 times

Urology News - Urinary incontinence following prostate surgery (post-prostatectomy incontinence or PPI) is a significant complication that can have a profoundly negative impact on the quality of...

  • “It is important that units undertaking prostatectomy of any nature, particularly radical prostatectomy, are able to accurately assess the incidence of PPI early and identify patients who may benefit from surgical intervention” https://t.co/HvoYzGbDxc

AUA Research Weekend (2020) | AUA University

posted 3 hours

Shared 1 times

auau.auanet.org - Basic Sciences Symposium: Novel Technologies for Benign Urology ResearchWelcome and Opening Remarks, Margot Damaser, PhD and Robert W. Gereau IV, PhDSession One: Tissue Engineering...

UroToday - Alicia Morgans and Christopher Sweeney discuss the IMbassador250 trial results presented at the AACR 2020 virtual meeting. IMbassador250 is a phase III trial in...

Urology Times - Partner PerspectivesWhat is this?Applying Key Insights from the PROCEED Real-World Registry to Clinical PracticeSponsored by DendreonTremendous advances have been made in the field of...

  • Real-world data on the prostate cancer “revolution”: This Partner Perspective examines key insights from the PROCEED registry, a multicenter, open-label, observational registry of nearly 2,000 men with mCRPC. Read now: https://t.co/dOdnuWuwr0 sponsored by @DendreonNews